Evidence map›Paper›PMID 34711257›Full record

ArticleRetrovirology2021

Residues T

Sergio Castro-Gonzalez, Yuexuan Chen, Jared Benjamin, Yuhang Shi, Ruth Serra-Moreno

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sergio Castro-GonzalezDepartment of Chemistry, Umeå University, Umeå, Sweden.
Yuexuan ChenMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Jared BenjaminMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Yuhang ShiMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Ruth Serra-MorenoMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA. ruth_serra-moreno@urmc.rochester.edu.ORCID 0000-0002-1923-6414
University of Rochester Medical Center · USUmeå University · SE

Funding

X-ray Screening and Rapid Structure DeterminationP50AI150476 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EMERMAN, MICHAEL · 2019 to 2021
$14.4M
New insights into the interplay between HIV and the autophagy machineryR01AI155012 · NIAID · UNIVERSITY OF ROCHESTER · PI SERRA MORENO, RUTH · 2021 to 2025
$1.9M
national institute of allergy and infectious diseases P50AI150476NIAID NIH HHS P50 AI150476NIAID NIH HHS R01 AI155012
6 · The paper itself

Abstract

backgroundAutophagy plays an important role as a cellular defense mechanism against intracellular pathogens, like viruses. Specifically, autophagy orchestrates the recruitment of specialized cargo, including viral components needed for replication, for lysosomal degradation. In addition to this primary role, the cleavage of viral structures facilitates their association with pattern recognition receptors and MHC-I/II complexes, which assists in the modulation of innate and adaptive immune responses against these pathogens. Importantly, whereas autophagy restricts the replicative capacity of human immunodeficiency virus type 1 (HIV-1), this virus has evolved the gene nef to circumvent this process through the inhibition of early and late stages of the autophagy cascade. Despite recent advances, many details of the mutual antagonism between HIV-1 and autophagy still remain unknown. Here, we uncover the genetic determinants that drive the autophagy-mediated restriction of HIV-1 as well as the counteraction imposed by Nef. Additionally, we also examine the implications of autophagy antagonism in HIV-1 infectivity.

resultsWe found that sustained activation of autophagy potently inhibits HIV-1 replication through the degradation of HIV-1 Gag, and that this effect is more prominent for nef-deficient viruses. Gag re-localizes to autophagosomes where it interacts with the autophagosome markers LC3 and SQSTM1. Importantly, autophagy-mediated recognition and recruitment of Gag requires the myristoylation and ubiquitination of this virus protein, two post-translational modifications that are essential for Gag's central role in virion assembly and budding. We also identified residues T

conclusionsThis study provides evidence that autophagy antagonism is important for virus replication and suggests that the ability of Nef to counteract autophagy may have played an important role in mucosal transmission. Hence, disabling Nef in combination with the pharmacological manipulation of autophagy represents a promising strategy to prevent HIV spread.

Indexed as

Amino Acid MotifsAutophagosomesAutophagygag Gene Products, Human Immunodeficiency VirusHIV-1HIV InfectionsHumansLysosomesnef Gene Products, Human Immunodeficiency VirusProteolysisUbiquitinUbiquitinationgag Gene Products, Human Immunodeficiency Virusnef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1UbiquitinAutophagyGagHIV-1Nef

Identifiers

PMID34711257
PMCPMC8555152
OpenAlexW3211238795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.